Identification of Contrave:
No description |
Search images on Google Product Monograph
Active Ingredients:
- naltrexone hydrochloride, 8 MG
- bupropion hydrochloride, 90 MG
DIN: 02472945
Dosage Form(s): TABLET (EXTENDED-RELEASE)
Route(s) of Administration: ORAL
Schedule: Prescription
Company: BAUSCH HEALTH, CANADA INC.
ATC:
- A08 - ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS (ATC, WHO, Wiki)
- A08A - ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS (ATC, WHO)
- A08AA - Centrally acting antiobesity products (ATC, WHO)
- A08AA62 - BUPROPION AND NALTREXONE (WHO)
Packaging:
- Package size unit: No information
- Package type: No information
- Package size: No information
- Product information: 70/120